Actively Recruiting

Phase 1
Age: 40Years +
All Genders
NCT07036510

Safety of TimoD Sustained-Release Implant in Participants With Glaucoma or Ocular Hypertension Undergoing Cataract Surgery

Led by EyeD Pharma · Updated on 2025-06-25

18

Participants Needed

1

Research Sites

81 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to test a new method to deliver an approved medicine called Timolol in the eye of participants with glaucoma or ocular hypertension and requiring cataract surgery. The main questions it aims to answer are how safe are three different doses of the investigational drug is and how the body tolerates it. The study will also check: * how safely the implant is placed in and removed from the eye and how the body responds to the procedure, * if and the amount of Timolol released in the bloodstream, * if there is any positive effect on the pressure inside the eye.

CONDITIONS

Official Title

Safety of TimoD Sustained-Release Implant in Participants With Glaucoma or Ocular Hypertension Undergoing Cataract Surgery

Who Can Participate

Age: 40Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Able to give signed informed consent
  • In good general and mental health without ongoing clinically significant medical issues
  • Diagnosed with open-angle glaucoma or ocular hypertension and have age-related cataract eligible for intra-capsular intraocular lens placement
  • Undergoing successful, uncomplicated cataract surgery
Not Eligible

You will not qualify if you...

  • History of hypersensitivity or contraindications to beta-blockers
  • Using systemic or topical drugs that affect visual performance, pupil dilation, or iris structure
  • At significant risk from stopping ocular hypotensive medications
  • Having significant eye diseases other than ocular hypertension, glaucoma, or cataract

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Panama Eye Center

Panama City, Panama

Actively Recruiting

Loading map...

Research Team

E

EyeD Pharma

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

SEQUENTIAL

Primary Purpose

OTHER

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here